P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Volume : 5 Issue : 2 Year : 2021

Cost-Effectiveness of Pembrolizumab in Combination with Platinum-Based Chemotherapy in First-Line for Squamous and Nonsquamous Non Small-Cell Lung Cancer. Far from Economic Sustainability

EJMO & EJMO